Search results
Results From The WOW.Com Content Network
Three different forms of nitroglycerin: intravenous, sublingual spray, and the nitroglycerin patch. Nitroglycerin is used for the treatment of angina, acute myocardial infarction, severe hypertension, and acute coronary artery spasms. [1] [12] It may be administered intravenously, as a sublingual spray, or as a patch applied to the skin.
Sodium nitroprusside (SNP), sold under the brand name Nitropress among others, is a medication used to lower blood pressure. [3] This may be done if the blood pressure is very high and resulting in symptoms, in certain types of heart failure, and during surgery to decrease bleeding. [3]
A nitrovasodilator is a pharmaceutical agent that causes vasodilation (widening of blood vessels) by donation of nitric oxide (NO), [1] and is mostly used for the treatment and prevention of angina pectoris. This group of drugs includes nitrates (esters of nitric acid), which are reduced to NO in the body, as well as some other substances.
Information card published by the National Heart, Lung, and Blood Institute urging people with symptoms of angina to call the emergency medical services.. Because of the relationship between the duration of myocardial ischemia and the extent of damage to heart muscle, public health services encourage people experiencing possible acute coronary syndrome symptoms or those around them to ...
Sublingual nitroglycerin is used for acute coronary syndrome; Isosorbide mononitrate and isosorbide dinitrate are used for symptomatic relief when blood pressure <130/80 mmHg [17] Not to be used as monotherapy in chronic coronary syndrome; An image of sublingual nitroglycerin tablets (Nitrostat) Caution. Avoid concomitant use of PDE-5 inhibitors
Transdermal scopolamine is commonly used as a treatment for motion sickness. [8] The anti-hypertensive drug clonidine is available in transdermal patch form. [9] Emsam, a transdermal form of the MAOI selegiline, became the first transdermal delivery agent for an antidepressant approved for use in the U.S. in March 2006. [10]
William Murrell (1853–1912) was an English physician, clinical pharmacologist, and toxicologist. Murrell is best known for being one of the first to recognize the clinical benefits of glyceryl trinitrate (also known as nitroglycerin) for the management of patients with angina pectoris.
Nitroglycerin (NG) (alternative spelling nitroglycerine), also known as trinitroglycerol (TNG), nitro, glyceryl trinitrate (GTN), or 1,2,3-trinitroxypropane, is a dense, colorless or pale yellow, oily, explosive liquid most commonly produced by nitrating glycerol with white fuming nitric acid under conditions appropriate to the formation of the nitric acid ester.